FDA plans to approve Moderna for Emergency Use

The United States Food and Drug Administration's officials have stated that they plan on moving ahead with authorizing Moderna’s COVID-19 vaccine. Dr. Stephen Hahn, FDA Commissioner said in a statement that the FDA has informed the sponsor that it will be working rapidly towards the issuance and finalization of an emergency use authorization.

The statement also said that the agency has notified Operation Warp Speed and the Centres for Disease Control and Prevention so that they can efficiently execute their plans for the vaccine distribution. The committee had voted 20-0 with one abstention for the Moderna Vaccine, which is very similar in composition, design, safety, and efficacy to Pfizer vaccine.

Moderna, a US Biotech company, in a recent announcement informed that it has submitted the results of trials and plans on requesting an emergency use authorisation from the US FDA. The clinical trials proved to be 100% only in emergency cases, with the vaccine trials being less effective. However, with more tests conducted, Moderna stated that the vaccines are 94% effective and that they will soon be submitting them to the FDA as well.

The White House credited the latest development on the COVID vaccine to Donald Trump’s ingenuity at work. According to its Press Secretary, President Trump’s Operation Warp Speed has shown astounding success by delivering multiple COVID vaccines in record time.